Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.52973 | 58 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.383 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.37353 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.24695 | 53 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.27882 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.58086 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.66275 | 60 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.35879 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.27625 | 53 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.32479 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.41056 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.30816 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.41566 | 56 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.37621 | 55 |